Correlation Between Milestone Scientific and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Milestone Scientific and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Scientific and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Milestone Scientific and Vivos Therapeutics, you can compare the effects of market volatilities on Milestone Scientific and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Scientific with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Scientific and Vivos Therapeutics.

Diversification Opportunities for Milestone Scientific and Vivos Therapeutics

-0.8

Correlation Coefficient

Milestone Scientific  Vivos Therapeutics

Pay attention - limited upside

The 3 months correlation between Milestone and Vivos is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Scientific and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Milestone Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Scientific are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Milestone Scientific i.e., Milestone Scientific and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Milestone Scientific and Vivos Therapeutics

Given the investment horizon of 90 days Milestone Scientific is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Scientific is 1.29 times less risky than Vivos Therapeutics. The stock trades about -0.08 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  306.00  in Vivos Therapeutics on May 15, 2025 and sell it today you would earn a total of  169.00  from holding Vivos Therapeutics or generate 55.23% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Milestone Scientific  vs.  Vivos Therapeutics

Milestone Scientific

Risk-Adjusted Performance

Weakest

Over the last 90 days Milestone Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in September 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Vivos Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Milestone Scientific and Vivos Therapeutics

The main advantage of trading using opposite Milestone Scientific and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Scientific position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Milestone Scientific and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.